
Management of HBV and HBV/HDV-Associated Liver Cirrhosis
Author(s) -
Christoph Höner zu Siederdissen,
Markus Cornberg
Publication year - 2016
Publication title -
visceral medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.598
H-Index - 17
eISSN - 2297-475X
pISSN - 2297-4725
DOI - 10.1159/000445518
Subject(s) - cirrhosis , medicine , hepatocellular carcinoma , hepatitis b virus , hepatitis d , liver transplantation , hepatitis b , hepatitis d virus , pegylated interferon , gastroenterology , liver disease , liver function , entecavir , immunology , virus , virology , transplantation , hepatitis c virus , lamivudine , hbsag , ribavirin
Chronic hepatitis B virus (HBV) infection and hepatitis delta virus (HDV) co-infection lead to liver cirrhosis, hepatic decompensation, and hepatocellular carcinoma (HCC).